Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Guilpain

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
La Revue De Medecine Interne|January 24, 2021
[Management of immune-related toxicities associated with immune checkpoints inhibitors: Data from the multidisciplinary meeting « ToxImmun » in Eastern Occitania]V Rivet, X Quantin, J L Faillie, et al.
La Revue De Medecine Interne|February 22, 2024
[Severe small bowel involvement and chronic intestinal pseudo-obstruction in systemic sclerosis (scleroderma): Pathophysiological, diagnostic and therapeutic basis, including parenteral nutrition]B Suzon, F Louis-Sidney, A Abel, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
La Revue De Medecine Interne|January 24, 2021
[Management of immune-related toxicities associated with immune checkpoints inhibitors: Data from the multidisciplinary meeting « ToxImmun » in Eastern Occitania]V Rivet, X Quantin, J L Faillie, et al.
La Revue De Medecine Interne|February 22, 2024
[Severe small bowel involvement and chronic intestinal pseudo-obstruction in systemic sclerosis (scleroderma): Pathophysiological, diagnostic and therapeutic basis, including parenteral nutrition]B Suzon, F Louis-Sidney, A Abel, et al.
Thorax|September 2, 2005
Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertensionM C Tamby, Y Chanseaud, M Humbert, et al.
European Journal of Internal Medicine|October 30, 2021
Off-label use of biologics for the treatment of refractory and/or relapsing granulomatosis with polyangiitisC Mettler, C A Durel, P Guilpain, et al.
Pageof 4